Pfizer 2Q13 2Q Revenues: $13.0 billion (-7%) 2Q Earnings: $14.1 billion (+333%)* YTD Revenues: $25.4 billion (-9%) YTD Earnings: $16.9 billion (+234%)* Comments: Lipitor sales worldwide dropped nearly $700 million in 2Q13 to $545 million (-55%), while overall pharma revenues fell $1.0 billion (-8%) to $12.1 billion. Lyrica posted a 10% gain to $1.1 billion, while changes in buying patterns led to a 3% drop for Prevnar vaccines ($970 million). New drugs Inlyta and Xalkori posted revenues of ...